Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
Michael E. Ray, Larry B. Levy, Eric M. Horwitz, Patrick A. Kupelian, Alvaro A. Martinez, Jeff M. Michalski, Thomas M. Pisansky, Michael J. Zelefsky, Anthony L. Zietman, Deborah A. Kuban
Dive into the research topics of 'Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure'. Together they form a unique fingerprint.